Ayako Nagayama, Tetsuaki Inokuchi, Kenji Ashida, Chizuko Inada, Tomoki Homma, Hiroshi Miyazaki, Takeki Adachi, Shimpei Iwata, Seiichi Motomura, Masatoshi Nomura. Assessing the Metabolic and Physical Effects of Combined DPP4 and SGLT2 Inhibitor Therapy in Patients with Type-2 Diabetes Mellitus: An Observational Prospective Pilot Study. JMA journal. 2024. 7. 3. 387-400
Yuji Tajiri, Yuka Goto, Yuko Matsuo, Yui Nakamura, Yoshie Otsuka, Moeko Sakamoto, Masaharu Kabashima, Ayako Nagayama, Mamiko Yano, Shimpei Iwata, et al. A Survey of Sleep Condition in Japanese Patients with Diabetes. Journal of the Japan Diabetes Society. 2022. 65. 9. 497-504
Satoko Oda, Kenji Ashida, Makiko Uchiyama, Shohei Sakamoto, Nao Hasuzawa, Ayako Nagayama, Lixiang Wang, Hiromi Nagata, Ryuichi Sakamoto, Junji Kishimoto, et al. An open-label phase I/II a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion. The Journal of clinical endocrinology and metabolism. 2021. 106. 10. e3865-e3880
Ayako Nagayama, Kenji Ashida, Miki Watanabe, Kanoko Moritaka, Aya Sonezaki, Yoichiro Kitajima, Hirokazu Takahashi, Satoko Yoshinobu, Shimpei Iwata, Junichi Yasuda, et al. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy. Frontiers in endocrinology. 2021. 12. 690996-690996
Ayako Nagayama, Kenji Ashida, Kanoko Moritaka, Mami Hidaka, Mizuki Gobaru, Seiji Tanaka, Nao Hasuzawa, Shoko Akasu, Yuka Goto, Seiichi Motomura, et al. Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report. Journal of the Endocrine Society. 2019. 3. 11. 2179-2183